Cardinal Systems is a full service CRO with added-value in International Project Management, Regulatory, Methodology, Statistics and Technology.
In line with the Critical Path Initiative (FDA) and the Road Map to 2015 (EMA), Cardinal Systems proposes innovative designs (e.g. adaptive design methods for clinical trials) and robust technology to optimise new drug development for unmet medical needs.
Cardinal Systems offers clinical trial management with high added-value since 1996 to pharmaceutical industries, biotechnologies and governmental and non profit organizations in the development of new therapeutics.
Cardinal Systems has been participating in healthcare improvement through international clinical trials in various indications.
Launched into the international clinical market through proprietary innovative solutions such as Interactive Voice And Web Randomisation System (IRS/IVRS/IWRS), EDC/eCRF, eCTD and Imaging Core Lab, Cardinal Systems continues to build long-term partnerships with its clients.
Cardinal Systems headquarter is located in Paris, France, with an affiliate in North America (Canada).
Specialised in innovative methodology (such as adaptive designs) and robust technology, Cardinal Systems offers global clinical trial services with high added-value to biotechnologies.
Supported by an international network of experts, we propose a streamlined and regulatory-compliant workflow and provide our client with data monitoring committee organisation and scientific guidance during clinical trials.
Cardinal Systems technology platform is 21CFR Part 11 compliant, with 24/7 online support.
Antoine Périer, CEO/Scientific & QA director. With over 25 years of experience in global clinical study management across Phase I-III development and Clinical Team Leadership roles, Antoine has acquired a wealth of experience in project management, CRO structuration and direction. His long experience has equipped him with valuable knowledge and provided him with a solid understanding of FDA/EMA requirements and potential challenges frequently encountered within the implementation and execution process of clinical trials.
François Aubin, MD, MSc, physician and biostatistician, is the Medical and Methodology Director at Cardinal Systems since 2008 and is president of the EFSPI and vice-president of the SFdS-Biopharmacy et Santé group.
All projects contracted to Cardinal Systems are overseen by at least one of these senior staff members.